Endurant Capital Management LP Edwards Lifesciences Corp Transaction History

Endurant Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $3.85 Million - $5.72 Million	-44,561 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $4.54 Million - $5.72 Million	44,561 New	44,561 $5.25 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $176,636 - $216,713	-3,806 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $173,934 - $220,862	3,806 New	3,806 $663,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $454,313 - $579,649	-12,216 Closed	0 $0

Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $20,274 - $23,634	600 Added 5.17%	12,216 $1.38 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $421,544 - $451,049	11,616	11,616 $1.27 Million

1,376

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.